Aiforia Technologies Plc
Aiforia provides AI-powered image analysis solutions for pathology, assisting pathologists and scientists in preclinical and clinical labs.
About
Aiforia is a Helsinki-based life-science company that provides deep learning AI solutions for pathology. They offer software solutions that elevate diagnostic capabilities in image analysis, enabling medical discoveries. Their platform equips pathologists and scientists in preclinical and clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. Teams look it up for HealthTech, Biotechnology, Artificial Intelligence.
Frequently asked
What does Aiforia Technologies Plc do?
Aiforia Technologies Plc is a HealthTech company that offers Software. Teams look it up for Biotechnology, Artificial Intelligence, Medical Devices. It is based in Helsinki, Finland and was founded in 2013. Public records show about 4 people and $22M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Is Aiforia Technologies Plc trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Aiforia Technologies Plc is 20 out of 100, based on site security posture and privacy practices.
How much funding has Aiforia Technologies Plc raised?
Aiforia Technologies Plc has raised a total of $22M in funding. The most recent round on record is Debt.
Where is Aiforia Technologies Plc headquartered?
Aiforia Technologies Plc is headquartered in Helsinki, Finland.
When was Aiforia Technologies Plc founded?
Aiforia Technologies Plc was founded in 2013.
What industry does Aiforia Technologies Plc operate in?
Aiforia Technologies Plc operates in HealthTech, Biotechnology, Artificial Intelligence, Medical Devices, Biotech.
Paige (acquired)
Tempus AI acquired Paige, a digital pathology company that develops AI-assisted diagnostic and biomarker applications, directly competing with Aiforia's AI-powered image analysis solutions for pathology.
PathAI (acquired)
Roche is acquiring PathAI, a digital pathology firm specializing in AI-powered technology for pathology laboratories and the biopharma industry, which directly competes with Aiforia's offerings in AI-driven pathology image analysis.
Leica Biosystems (with Indica Labs partnership)
Danaher's operating company, Leica Biosystems, has a strategic investment and partnership with Indica Labs, a leader in AI-powered digital pathology software, creating a competing platform for AI-enabled cancer diagnostics.
Philips Digital Pathology Solutions
Philips offers end-to-end digital pathology platforms that leverage AI and cloud-based solutions for remote collaboration and clinical standardization, directly competing with Aiforia's AI-powered image analysis for pathology.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.